Medicare.gov

Coronavirus disease 2019 (COVID-19) monoclonal antibody treatments & products

Medicare Part B (Medical Insurance) covers FDA-authorized or -approved COVID-19 monoclonal antibody treatments and products if you have COVID-19 symptoms

  • Covered by Part B

  • You usually pay nothing

Description

COVID-19 monoclonal antibody treatments and products can help you fight mild to moderate COVID-19 and keep you out of the hospital. This treatment involves an infusion of monoclonal antibodies (specifically bamlanivimab, or casirivimab and imdevimab) to treat COVID-19. Health care providers can only give the infusions in certain settings. 

Coverage details

Medicare also covers  COVID-19 antibody tests,  COVID-19 monoclonal antibody treatments, and COVID-19 vaccines. 

Costs

You pay nothing for a monoclonal antibody treatment when you get it from a Medicare provider or supplier. You must meet certain conditions to qualify. If you're in a Medicare Advantage Plan, check with your plan about your coverage and costs.

Certain FDA-authorized or -approved monoclonal antibody products can protect you before you’re exposed to COVID-19. If you have Part B and your doctor or other health care provider decides this type of product could work for you (like if you have a weakened immune system), you pay nothing when you get the product from a Medicare provider or supplier. 

Ask your doctor or healthcare provider how much your test, item, or service will cost.

Your doctor may recommend services that Medicare does not cover or offers too frequently. This could end up in additional costs for you. Make sure to ask your doctor about the reasons for these recommendations and what Medicare will actually cover.

Specific amounts you could owe depend on:

  • Other insurance you may have

  • How much your doctor charges

  • If your doctor accepts assignment

  • The type of facility

  • Where you get your test, item, or service

Other related information